Senior Director, Marketing - US Biosimilars
Lupin
Summary
The Senior Director, Marketing – US Biosimilars will be a commercial leader responsible for leading US biosimilars portfolio strategy and developing and executing marketing and commercial strategies for pipeline, launch, and in-line biosimilar products. The Senior Director will lead integrated launch planning, generate market and competitive insights, evaluate post-launch performance, and coordinate with cross-functional partners to develop and execute strategies designed to achieve agreed market share, volume, revenue, margin, and profitability objectives.
Job description
Key Responsibilities
Commercial and Portfolio Strategy
- Lead US biosimilars portfolio strategy, pipeline assessment, opportunity prioritization, sequencing, and resource recommendations.
- Translate market, customer, payer, reimbursement, pricing, contracting, and competitive insights into differentiated commercial strategies.
- Maintain market and competitor intelligence and recommend portfolio priorities and investment decisions.
Launch and Product Leadership
- Lead integrated commercial planning and readiness for biosimilar launches and in-line products.
- Establish and evaluate performance measures for market share, volume, revenue, margin, and profitability; recommend corrective actions.
- Direct customer-facing strategies and materials with Sales, Market Access, Medical Affairs, Regulatory, Legal/Compliance, Finance, Analytics, and Commercial Operations.
Cross-Functional Leadership and Analytics
- Lead complex initiatives across a matrixed organization and align stakeholders on priorities, timelines, risks, and objectives.
- Communicate strategies, performance, risks, and recommendations to senior leadership and participate in customer meetings as needed.
- Use research, forecasting, competitive intelligence, and analytics to generate insights, dashboards, and executive recommendations.
Requirements
- BA/BS degree and 10+ years of relevant pharmaceutical-industry experience.
- At least 1 year of direct commercial biosimilars experience.
- Experience leading portfolio strategy, commercial assessment, pipeline prioritization, complex launches, in-line product management, or a combination of these areas.
- Director-level or comparable scope demonstrating strategic ownership, cross-functional leadership, senior-stakeholder influence, business accountability, and measurable impact; prior Director title not required.
- Understanding of US biosimilar market access, reimbursement, commercialization, customer strategy, adoption, and pharmaceutical regulatory/compliance requirements.
- Experience with forecasting, market research, competitive intelligence, and commercial analytics.
- Strong matrix leadership, communication, presentation, prioritization, and project-management skills.
- Proficiency in Excel, PowerPoint, Word, Outlook, and Teams.
Benefits
- Performance Bonus
- Long-Term Incentive
Company overview
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with a significant presence in over 100 countries worldwide. Founded in 1968 by Desh Bandhu Gupta, the company has grown into one of India's top pharmaceutical manufacturers and a major global player in the generic drug market. Lupin specializes in a comprehensive range of pharmaceutical products including branded and generic formulations, complex generics, biotechnology products, active pharmaceutical ingredients (APIs), and advanced drug delivery systems. The company maintains a strong therapeutic focus across multiple areas including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. With 15 state-of-the-art manufacturing facilities and 7 research centers globally, Lupin employs over 20,000 professionals dedicated to improving patient health outcomes. The company's U.S. subsidiary, Lupin Pharmaceuticals Inc., operates from Baltimore, Maryland, and has established itself as a significant player in the American pharmaceutical market. Lupin's commitment to innovation, quality, and accessibility has positioned it as a trusted provider of healthcare solutions that address unmet medical needs while maintaining a strong focus on sustainability and corporate social responsibility.